DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Issa JP, Garcia-Manero G, Giles FJ. et al.
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies.
Blood 2004; 103: 1635-1640
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.